Sumitomo Chemical Company, Limited (TYO:4005)
Japan · Delayed Price · Currency is JPY 593.40
-9.60 (-1.59%)
May 26, 2026, 3:30 PM JST
Sumitomo Chemical Company Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 2,328,515 | 2,606,281 | 2,446,893 | 2,895,283 | 2,765,321 | |
Revenue Growth (YoY) | -10.66% | 6.51% | -15.49% | 4.70% | 20.92% |
Cost of Revenue | 1,660,247 | 1,880,805 | 1,947,198 | 2,074,357 | 1,891,458 |
Gross Profit | 668,268 | 725,476 | 499,695 | 820,926 | 873,863 |
Selling, General & Admin | 565,505 | 413,860 | 651,535 | 629,717 | 466,657 |
Research & Development | - | 141,734 | 179,062 | 191,181 | 171,923 |
Other Operating Expenses | -92,252 | 14,217 | 6,489 | -8 | 1,436 |
Operating Expenses | 473,253 | 615,291 | 893,613 | 878,253 | 692,296 |
Operating Income | 195,015 | 110,185 | -393,918 | -57,327 | 181,567 |
Interest Expense | -50,176 | -28,704 | -29,234 | -22,468 | -16,111 |
Interest & Investment Income | 27,400 | 15,831 | 22,139 | 18,730 | 9,976 |
Earnings From Equity Investments | -43,271 | 20,639 | -57,398 | -6,797 | 42,180 |
Currency Exchange Gain (Loss) | 700 | -6,178 | 49,254 | 40,107 | 45,602 |
Other Non Operating Income (Expenses) | - | -108,559 | 1,419 | 6 | -2,663 |
EBT Excluding Unusual Items | 129,668 | 3,214 | -407,738 | -27,749 | 260,551 |
Merger & Restructuring Charges | - | -23,583 | -48,397 | -22,100 | -10,133 |
Gain (Loss) on Sale of Investments | -13,600 | 12,238 | -6,114 | - | - |
Gain (Loss) on Sale of Assets | - | 70,992 | 16,229 | 54,380 | 718 |
Asset Writedown | - | -4,768 | -16,772 | -4,300 | - |
Pretax Income | 116,068 | 58,093 | -462,792 | 231 | 251,136 |
Income Tax Expense | 666 | 15,405 | 2,657 | 47,096 | 64,699 |
Earnings From Continuing Operations | 115,402 | 42,688 | -465,449 | -46,865 | 186,437 |
Minority Interest in Earnings | -54,455 | -4,097 | 153,611 | 53,852 | -24,307 |
Net Income | 60,947 | 38,591 | -311,838 | 6,987 | 162,130 |
Net Income to Common | 60,947 | 38,591 | -311,838 | 6,987 | 162,130 |
Net Income Growth | 57.93% | - | - | -95.69% | 252.13% |
Shares Outstanding (Basic) | 1,640 | 1,636 | 1,635 | 1,635 | 1,635 |
Shares Outstanding (Diluted) | 1,641 | 1,637 | 1,635 | 1,635 | 1,635 |
Shares Change (YoY) | 0.26% | 0.07% | 0.01% | 0.02% | -0.00% |
EPS (Basic) | 37.16 | 23.59 | -190.69 | 4.27 | 99.16 |
EPS (Diluted) | 37.15 | 23.58 | -190.69 | 4.27 | 99.16 |
EPS Growth | 57.55% | - | - | -95.69% | 252.13% |
Free Cash Flow | 113,193 | 102,562 | -204,190 | -31,960 | 64,248 |
Free Cash Flow Per Share | 68.99 | 62.67 | -124.86 | -19.54 | 39.30 |
Dividend Per Share | 13.500 | 9.000 | 9.000 | 18.000 | 24.000 |
Dividend Growth | 50.00% | - | -50.00% | -25.00% | 60.00% |
Gross Margin | 28.70% | 27.84% | 20.42% | 28.35% | 31.60% |
Operating Margin | 8.38% | 4.23% | -16.10% | -1.98% | 6.57% |
Profit Margin | 2.62% | 1.48% | -12.74% | 0.24% | 5.86% |
Free Cash Flow Margin | 4.86% | 3.94% | -8.34% | -1.10% | 2.32% |
EBITDA | 316,084 | 241,782 | -236,396 | 110,630 | 338,234 |
EBITDA Margin | 13.57% | 9.28% | -9.66% | 3.82% | 12.23% |
D&A For EBITDA | 121,069 | 131,597 | 157,522 | 167,957 | 156,667 |
EBIT | 195,015 | 110,185 | -393,918 | -57,327 | 181,567 |
EBIT Margin | 8.38% | 4.23% | -16.10% | -1.98% | 6.57% |
Effective Tax Rate | 0.57% | 26.52% | - | 20387.88% | 25.76% |
Advertising Expenses | - | 36,133 | 53,979 | 70,684 | 47,297 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.